Podcast – A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid Tumors Jillian Romeo2021-04-30T08:06:37-04:00 Podcast – A Modern Trojan Horse: Delivering Combination Immunotherapies to Solid TumorsJillian Romeo2021-04-30T08:06:37-04:00
Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor Activity IsoPlexis2021-05-06T09:56:28-04:00 Delivery of Oncolytic Immunotherapy by MSCs Enhances CAR-T Cell Anti-Tumor ActivityIsoPlexis2021-05-06T09:56:28-04:00
Identifying Prognostic Biomarkers of Inflammation in COVID-19 with Functional Immune Landscaping IsoPlexis2021-05-05T11:39:41-04:00 Identifying Prognostic Biomarkers of Inflammation in COVID-19 with Functional Immune LandscapingIsoPlexis2021-05-05T11:39:41-04:00
Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular Identity IsoPlexis2021-04-27T23:18:46-04:00 Advances in Single-Cell Proteomics: Building a Complete Picture of Cellular IdentityIsoPlexis2021-04-27T23:18:46-04:00
Case Study: Analyzing Tumor Cell Resistance Pathways with Single-Cell Intracellular Proteome IsoPlexis2021-04-27T23:17:16-04:00 Case Study: Analyzing Tumor Cell Resistance Pathways with Single-Cell Intracellular ProteomeIsoPlexis2021-04-27T23:17:16-04:00
Single-Cell Proteomic Pathway Omics [email protected]2021-04-28T05:23:31-04:00 Single-Cell Proteomic Pathway Omics[email protected]2021-04-28T05:23:31-04:00
IsoPlexis’ IsoSpark Receives 2021 Red Dot Award for Product Design and Innovation IsoPlexis2021-04-27T23:17:17-04:00 IsoPlexis’ IsoSpark Receives 2021 Red Dot Award for Product Design and InnovationIsoPlexis2021-04-27T23:17:17-04:00
IsoPlexis’ IsoSpark Instrument Wins Red Dot Design Award for Highest Design Quality and Innovative Approach [email protected]2021-04-28T05:03:08-04:00 IsoPlexis’ IsoSpark Instrument Wins Red Dot Design Award for Highest Design Quality and Innovative Approach[email protected]2021-04-28T05:03:08-04:00
Visit our Virtual Exhibit at AACR 2021 IsoPlexis2021-04-27T23:17:17-04:00 Visit our Virtual Exhibit at AACR 2021IsoPlexis2021-04-27T23:17:17-04:00
Functional Profiling of CRISPR-Edited Cells Identifies Potent and Durable Immune Therapies [email protected]2021-04-28T05:23:33-04:00 Functional Profiling of CRISPR-Edited Cells Identifies Potent and Durable Immune Therapies[email protected]2021-04-28T05:23:33-04:00
